Monster Beverage's $280M Volume Ranks 380th as Institutional Bulls and Bears Battle Over Holdings

Generated by AI AgentAinvest Volume Radar
Thursday, Sep 4, 2025 7:00 pm ET1min read
Aime RobotAime Summary

- Monster Beverage's stock fell 0.09% on 2025/9/4 with $280M volume, ranking 380th in trading activity.

- Institutional investors showed mixed positions: Nomura cut 6.6% stake while Migdal and Cary Street boosted holdings by 37.1% and 21.2%.

- Analyst ratings split between Redburn's "Hold" at $60 and Citigroup/RBC's "Buy" at $74-$68, despite Q2 EPS beat and 11.1% revenue growth.

- Director Vidergauz sold 10,000 shares ($637K) reducing ownership by 16.34%, as stock traded near 52-week low at $45.70.

- Backtests confirm valuation consistency (P/E 38.76, beta 0.54), but mixed technical indicators and insider transactions suggest short-term volatility risks.

On September 4, 2025,

(NASDAQ: MNST) closed with a 0.09% decline, trading with a $0.28 billion volume ranked 380th in the market. Institutional activity highlighted shifting ownership dynamics, with Inc. reducing its stake by 6.6% in Q1, trimming 4,396 shares to 61,863, while entities like Migdal Insurance & Financial Holdings Ltd. and Cary Street Partners increased holdings by 37.1% and 21.2% respectively. The company’s stock is held 72.36% by institutions, reflecting sustained institutional confidence despite recent strategic rebalancing.

Analyst sentiment remained mixed, with Redburn Atlantic downgrading

to "Hold" from "Strong-Buy" and lowering its price target to $60, while and maintained "Buy" ratings with targets of $74 and $68. Internal activity included Director Mark Vidergauz selling 10,000 shares for $637,300, reducing his ownership by 16.34%. The company reported Q2 EPS of $0.52, exceeding estimates, with revenue rising 11.1% year-over-year to $2.11 billion. Despite these results, the stock traded near its 52-week low of $45.70, with a market cap of $60.94 billion.

Backtest results indicate MNST’s historical performance aligns with its current valuation metrics, including a P/E ratio of 38.76 and beta of 0.54. Institutional ownership and analyst ratings suggest continued strategic interest, though short-term volatility remains a factor given mixed technical indicators and insider transactions.

Comments



Add a public comment...
No comments

No comments yet